Anzeige
Mehr »
Login
Montag, 23.12.2024 Börsentäglich über 12.000 News von 679 internationalen Medien
Die erste börsennotierte Gesellschaft, die auf das gemeinsame Wachstum von Solana, XRP und Dogecoin setzt!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A0RDRL | ISIN: GB00B3FLWH99 | Ticker-Symbol: 21T
München
23.12.24
08:18 Uhr
7,650 Euro
-0,050
-0,65 %
Branche
Maschinenbau
Aktienmarkt
FTSE-250
1-Jahres-Chart
BODYCOTE PLC Chart 1 Jahr
5-Tage-Chart
BODYCOTE PLC 5-Tage-Chart
RealtimeGeldBriefZeit
7,5007,75015:39
PR Newswire
200 Leser
Artikel bewerten:
(1)

Bodycote Plc - Extension of Share Buyback Programme

Finanznachrichten News

Bodycote Plc - Extension of Share Buyback Programme

PR Newswire

LONDON, United Kingdom, December 23

23 December 2024

Bodycote plc

Extension of share buyback programme

Further to the announcement made on 12 December 2024, Bodycote plc ("Company"), the world's leading provider of heat treatment and specialist thermal processing services, today confirms its intention to extend the current share buyback programme, as originally announced on 15 March 2024 ('Programme'), by a further £30 million, resulting in a total maximum aggregate consideration of £90 million being allocated to the Programme.

On 22 January 2024, Bodycote announced a plan to return £60 million to shareholders to be completed by March 2025. The first £30 million tranche of the Programme, undertaken by HSBC Bank plc ('HSBC'), commenced on 15 March 2024 and concluded on 23 July 2024. The second £30 million tranche of the Programme, which commenced on 30 July 2024 and is being undertaken by Jefferies, is now largely complete and will conclude by 30 January 2025.

The Company has now entered into a further agreement with HSBC to execute an additional £30 million share buyback as an extension to the original Programme (the 'Extended Programme') to start immediately following completion of the second tranche of the programme. Under this arrangement, HSBC will carry out on-market purchases of ordinary shares . HSBC will make its trading decisions in relation to the Extended Programme independently of, and uninfluenced by, the Company. Purchases may continue during any close period to which the Company is subject during the Extended Programme.

The Extended Programme will otherwise continue to be subject to the same parameters, and for the same purpose, as set out in the Company's announcement of 15 March 2024, in particular with respect to the volume of shares that can be traded. The maximum number of shares which can be repurchased under the Programme is currently 13,408,869. The Extended Programme will be conducted at all times within the limits of the applicable authority granted by shareholders at the 2024 AGM to repurchase the Company's ordinary shares in issue and, post the 2024 AGM, if approval is granted by the shareholders, in accordance with the general authority to repurchase shares granted at that meeting. It is anticipated that the Extended Programme will end no later than July 2025.

This Extended Programme will be conducted in accordance with the Company's general authority to repurchase Ordinary Shares, Chapter 9 of the FCA's Listing Rules, and in accordance with the parameters prescribed by the Market Abuse Regulation 596/2014 (as it forms part of UK law pursuant to the European Union (Withdrawal) Act 2018). Share purchases in relation to the Extended Programme will be carried out on the open market via the London Stock Exchange and/or other recognised investment exchange(s) for the purposes of section 693 of the Companies Act 2006 and may be made from time to time depending on market conditions, share price, trading volume and other factors. Purchases may continue during any closed period to which the Company is subject during the engagement period.

About Bodycote

With more than 155 accredited facilities in 22 countries, Bodycote is the world's largest provider of thermal processing services. Through Specialist Technologies and Precision Heat treatment, Bodycote improves the properties of metals and alloys, extending the life of vital components for a wide range of industries, including aerospace, defence, automotive, power generation, medical, oil & gas, construction, and transportation. Customers in all of these industries have entrusted their products to Bodycote's care for more than 50 years. For more information, visit www.bodycote.com.

For further information, please contact:

Bodycote plc

Jim Fairbairn, Chief Executive Officer

Ben Fidler, Chief Financial Officer

Peter Lapthorn, Investor Relations and FP&A

Tel: +44 1625 505 300

FTI Consulting

Richard Mountain

Susanne Yule

Tel: +44 203 727 1340




© 2024 PR Newswire
Treibt Nvidias KI-Boom den Uranpreis?
In einer Welt, in der künstliche Intelligenz zunehmend zum Treiber technologischer Fortschritte wird, rückt auch der Energiebedarf, der für den Betrieb und die Weiterentwicklung von KI-Systemen erforderlich ist, in den Fokus.

Nvidia, ein Vorreiter auf dem Gebiet der KI, steht im Zentrum dieser Entwicklung. Mit steigender Nachfrage nach leistungsfähigeren KI-Anwendungen steigt auch der Bedarf an Energie. Uran, als Schlüsselkomponente für die Energiegewinnung in Kernkraftwerken, könnte dadurch einen neuen Stellenwert erhalten.

Dieser kostenlose Report beleuchtet, wie der KI-Boom potenziell den Uranmarkt beeinflusst und stellt drei aussichtsreiche Unternehmen vor, die von diesen Entwicklungen profitieren könnten und echtes Rallyepotenzial besitzen

Handeln Sie Jetzt!

Fordern Sie jetzt den brandneuen Spezialreport an und profitieren Sie von der steigenden Nachfrage, der den Uranpreis auf neue Höchststände treiben könnte.
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.